Literature DB >> 3360269

Hepatic and bile porphyrins in patients with protoporphyria and liver failure.

K O Morton1, F Schneider, M K Weimer, J G Straka, J R Bloomer.   

Abstract

The livers of patients who have protoporphyria and hepatic failure contain large amounts of pigment crystals. Two such patients underwent liver transplantation, providing the opportunity to identify the pigment crystals. Portions of liver were digested enzymically, sedimented through a sucrose gradient, treated with 1% sodium dodecylsulfate, and centrifuged to purify the crystals. Spectrophotometric and high-performance liquid chromatography analysis demonstrated them to be composed of protoporphyrin. Bile samples were obtained from the 2 patients, 4 other patients who did not have liver disease, and 10 control subjects. The porphyrin concentrations in bile from the 6 patients were significantly increased above controls (range 254-7884 micrograms/dl compared with 11-109 micrograms/dl). The ratio of protoporphyrin to bile acid in bile distinguished the 2 patients with advanced liver disease (3105 and 2756 micrograms/mmol) from the 4 patients without liver disease (range 61-926 micrograms/mmol). Thus, analysis of bile from patients with protoporphyria may help in evaluating their hepatobiliary status.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3360269     DOI: 10.1016/0016-5085(88)90690-7

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Toxic dark effects of protoporphyrin on the cytochrome P-450 system in rat liver microsomes.

Authors:  M Williams; J Van der Zee; J Van Steveninck
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation.

Authors:  J Bloomer; C Bruzzone; L Zhu; Y Scarlett; S Magness; D Brenner
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

3.  Immunochemical studies of ferrochelatase protein: characterization of the normal and mutant protein in bovine and human protoporphyria.

Authors:  J G Straka; H D Hill; J M Krikava; A M Kools; J R Bloomer
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

4.  UK experience of liver transplantation for erythropoietic protoporphyria.

Authors:  Joanna K Dowman; Briget K Gunson; Darius F Mirza; Mike N Badminton; Philip N Newsome
Journal:  J Inherit Metab Dis       Date:  2011-02-08       Impact factor: 4.982

5.  Level of expression of the nonmutant Ferrochelatase allele is a determinant of biochemical phenotype in a mouse model of erythropoietic protoporphyria.

Authors:  Joseph Bloomer; Yongming Wang; Dongquan Chen
Journal:  Gene Regul Syst Bio       Date:  2008-05-29

6.  Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.